{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:20:19Z","timestamp":1794500419841,"version":"4.9.1"},"reference-count":39,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The \u03b1-synuclein seed amplification assay (\u03b1S-SAA) represents a promising strategy for identifying individuals with \u03b1-synuclein pathology, empowering development of tailored Parkinson's disease (PD) therapeutics and clinical trial design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess the \u03b1S-SAA in cerebrospinal fluid (CSF) from PD patients, non-manifesting carriers (NMCs) and non-manifesting non-carriers (NMNCs) of pathogenic\n                      <jats:italic toggle=\"yes\">GBA1<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">LRRK2<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study collected phenotype data from participants in the single-center, longitudinal, natural history BEAT-PD study (TLV-0204-16), which included PD patients and high-risk individuals for whom CSF samples were collected at baseline and 2 years post baseline. Clinical assessments in high-risk individuals enabled calculation of the International Parkinson and Movement Disorder Society probability scores for prodromal PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CSF from 98 participants was evaluated, with no differences in age or sex distribution observed between PD and NMC subgroups. All iPD (14\/14) and\n                      <jats:italic toggle=\"yes\">GBA1<\/jats:italic>\n                      -PD (14\/14) participants were \u03b1S-SAA positive at baseline versus only 5\/13\n                      <jats:italic toggle=\"yes\">LRRK2<\/jats:italic>\n                      -PD participants (p\u2009&lt;\u20090.001); 44\/45 participants with longitudinal follow-up-maintained baseline \u03b1S-SAA status at year 2.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">LRRK2-<\/jats:italic>\n                      PD carriers, all who carried the G2019S variant, with and without positive \u03b1S-SAA status were similar in all phenotype characteristics, except for younger age at diagnosis among \u03b1S-SAA positive individuals (p\u2009=\u20090.04). Prodromal PD probability scores were higher in \u03b1S-SAA positive versus negative\n                      <jats:italic toggle=\"yes\">GBA1<\/jats:italic>\n                      -NMCs (p\u2009&lt;\u20090.001) and NMNCs (p\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In\n                      <jats:italic toggle=\"yes\">LRRK2-<\/jats:italic>\n                      PD, \u03b1S-SAA was associated with younger age of onset but not with motor or non-motor symptoms. In at-risk participants, \u03b1S-SAA\u2013positive status was associated with probability scores for prodromal PD. Longitudinal follow up is required to test if \u03b1S-SAA-positivity predicts future conversion to clinical PD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x251392799","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:37:57Z","timestamp":1769171877000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Analysis of \u03b1-synuclein seed amplification assay in carriers of\n                    <i>GBA1<\/i>\n                    and\n                    <i>LRRK2<\/i>\n                    pathogenic variants"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-4469","authenticated-orcid":false,"given":"Kyle B","family":"Fraser","sequence":"first","affiliation":[{"name":"Biogen Inc, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-2292","authenticated-orcid":false,"given":"Anat","family":"Mirelman","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S","family":"Mabrouk","sequence":"additional","affiliation":[{"name":"Biogen Inc, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1282-8051","authenticated-orcid":false,"given":"Nurit","family":"Omer","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Movement Disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9454-8389","authenticated-orcid":false,"given":"Luis","family":"Concha-Marambio","sequence":"additional","affiliation":[{"name":"Amprion Inc, San Diego, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-9848","authenticated-orcid":false,"given":"Tanya","family":"Gurevich","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel"},{"name":"Movement Disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8772-0303","authenticated-orcid":false,"given":"Anat","family":"Bar-Shira","sequence":"additional","affiliation":[{"name":"Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8505-0183","authenticated-orcid":false,"given":"Mali","family":"Gana-Weisz","sequence":"additional","affiliation":[{"name":"Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7781-2734","authenticated-orcid":false,"given":"Orly","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9305-6203","authenticated-orcid":false,"given":"Avi","family":"Orr-Urtreger","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Genomic Research Laboratory for Neurodegeneration, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3503-334X","authenticated-orcid":false,"given":"Meir","family":"Kestenbaum","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Neurology Department, Meir Medical Center, Kfar Saba, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-8784","authenticated-orcid":false,"given":"Jesse M","family":"Cedarbaum","sequence":"additional","affiliation":[{"name":"Biogen Inc, Cambridge, MA, USA"},{"name":"Coeruleus Clinical Sciences LLC, Woodbridge, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien","family":"Dam","sequence":"additional","affiliation":[{"name":"Former Biogen employee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C","family":"Shirvan","sequence":"additional","affiliation":[{"name":"Former Biogen employee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Giladi","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel"},{"name":"Movement Disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Graham","sequence":"additional","affiliation":[{"name":"Biogen Inc, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5717-4875","authenticated-orcid":false,"given":"Roy N","family":"Alcalay","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Movement Disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7629-8120","authenticated-orcid":false,"given":"Avner","family":"Thaler","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical Health and Sciences, Tel Aviv University, Tel Aviv, Israel"},{"name":"Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"},{"name":"Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel"},{"name":"Movement Disorders Center, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70238-8"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2294"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.4547"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27646"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30449-X"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26453"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00109-6"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3955"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00531"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp044"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29449"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01276-6"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.772"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26431"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27802"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27342"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26674"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117059"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000304039.11891.29"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2019.10.001"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.11.1401"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-015-1437-x"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20153"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2011.01.015"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.3758\/BF03210709"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23429"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28715"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01282-8"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf103"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.1.155"},{"key":"e_1_3_3_35_2","first-page":"100","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"71","author":"Kalia LV","year":"2014","unstructured":"Kalia LV, Lang AE, Hazrati LN, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 2014; 71: 100\u2013105.","journal-title":"JAMA Neurol"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.95"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00405-2"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00404-0"},{"key":"e_1_3_3_39_2","first-page":"85","article-title":"Gaucher disease: gene frequencies in the ashkenazi Jewish population","volume":"52","author":"Beutler E","year":"1993","unstructured":"Beutler E, Nguyen NJ, Henneberger MW, et al. Gaucher disease: gene frequencies in the ashkenazi Jewish population. Am J Hum Genet 1993; 52: 85\u201388.","journal-title":"Am J Hum Genet"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107940"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251392799","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X251392799","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251392799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:51:30Z","timestamp":1790254290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X251392799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/1877718X251392799"],"URL":"https:\/\/doi.org\/10.1177\/1877718x251392799","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}